• Member Statistics

    • 791,591 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • David E. Marcinko [Editor-in-Chief]

    As a former Dean and appointed Distinguished University Professor and Endowed Department Chair, Dr. David Edward Marcinko MBA was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.

    Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; as well as Oglethorpe University and Emory University in Georgia, the Atlanta Hospital & Medical Center; Kellogg-Keller Graduate School of Business and Management in Chicago, and the Aachen City University Hospital, Koln-Germany. He became one of the most innovative global thought leaders in medical business entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing non-essential expenditures and improving dated operational in-efficiencies.

    Professor David Marcinko was a board certified surgical fellow, hospital medical staff President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug, DME and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published academic text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].

    Dr. David E. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics trade journals and publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.

    Later, Dr. Marcinko was a vital recruited BOD member of several innovative companies like Physicians Nexus, First Global Financial Advisors and the Physician Services Group Inc; as well as mentor and coach for Deloitte-Touche and other start-up firms in Silicon Valley, CA.

    As a state licensed life, P&C and health insurance agent; and dual SEC registered investment advisor and representative, Marcinko was Founding Dean of the fiduciary and niche focused CERTIFIED MEDICAL PLANNER® chartered professional designation education program; as well as Chief Editor of the three print format HEALTH DICTIONARY SERIES® and online Wiki Project.

    Dr. David E. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA, FPA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”.

    Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.

    entrepreneur

    Frontal_lobe_animation

  • ME-P Information & Content Channels

  • ME-P Archives Silo [2006 – 2020]

  • Ann Miller RN MHA [Managing Editor]

    ME-P SYNDICATIONS:
    WSJ.com,
    CNN.com,
    Forbes.com,
    WashingtonPost.com,
    BusinessWeek.com,
    USNews.com, Reuters.com,
    TimeWarnerCable.com,
    e-How.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details

  • CERTIFIED MEDICAL PLANNER® program

    New "Self-Directed" Study Option SinceJanuary 1st, 2018
  • Most Recent ME-Ps

  • PodiatryPrep.org


    BOARD CERTIFICATION EXAM STUDY GUIDES
    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • ME-P Free Advertising Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

  • Medical & Surgical e-Consent Forms

    ePodiatryConsentForms.com
  • iMBA R&D Services

    Commission a Subject Matter Expert Report [$250-$999]January 1st, 2019
    Medical Clinic Valuations * Endowment Fund Management * Health Capital Formation * Investment Policy Statement Analysis * Provider Contracting & Negotiations * Marketplace Competition * Revenue Cycle Enhancements; and more! HEALTHCARE FINANCIAL INDUSTRIAL COMPLEX
  • iMBA Inc., OFFICES

    Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.

  • ME-P Publishing

  • SEEKING INDUSTRY INFO PARTNERS?

    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. ******************************************************************** THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov

Euro Currency in the Cross Hairs? [Video]

Join Our Mailing List

How We Got There –  A Review for Physician Investors

By Jonathan Reyes

It’s been two decades since the dream of a unified Europe inched toward a reality. But, as crises have taken hold and bail-outs have become commonplace, how has the continent’s shared currency weathered the storms?

Video Link: http://www.infographicsarchive.com/economics/video-infographic-the-euro-in-the-crosshairs-how-we-got-here

Source: Video infographic made for Bloomberg TV.

Assessment

Important information for all medical professsionals and retail physician investors interested in emerging markets or international investing.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

 

Product Details  Product Details

10 Responses

  1. Dow looks at 200-point gain on European Zone hopes

    ME-P; your staff must be mind readers.

    This just in as the blue chips see their biggest rally since March.

    http://money.msn.com/market-news/post.aspx?post=2473256f-60ed-44fd-8e8e-360be9b59482

    Investors are betting on lower rates in Europe and possibly more Fed action for a Euro-Zone fix.

    Dr. Gupta

    Like

  2. The US Markets

    I believe US equities will continue to rise on speculation the Fed will extend Operation Twist, a decisive GOP victory in the Wisconsin recall, a potential recapitalization of Spanish banks, or some combination of all of them.

    Dr. Raiford

    Like

  3. Global Growth

    Global growth prospects received a shot in the arm today from a surprising rate cut from the Chinese central bank.

    In its first rate cut since 2008, the People’s Bank of China knocked 25 basis points off its benchmark rate and lowered deposit rates. Monetary easing in the world’s second largest economy, paired with a drop in U.S. initial jobless claims, provided a much needed boost to sentiment in the face of yet another downgrade of Spanish debt.

    Dr. Gupta

    Like

  4. Global fiscal worries

    I agree – The economic challenges in the Eurozone and the ambiguity surrounding U.S. fiscal policy have cast a shadow over market activity.

    Giuseppe

    Like

  5. ECB

    The European Central Bank just cut its key interest rate to a historic low and extended unlimited cheap loans to banks to try and help the flagging euro area economy climb out of a stubborn recession.

    And, ECB President Mario Draghi held out the prospect that more help might be on the way.

    Sarita

    Like

  6. Jonathan,

    Can you answer the following Qs:

    • What’s behind the poor performance of EM this year, and are they now cheap or a value trap?

    • What are the longer-term arguments for holding EM equities in a portfolio?

    • For those investors looking to invest in EM equities, what are some ways to implement?

    Thanks!

    Raymond

    Like

  7. Ray,

    10 easy currency lessons:

    http://money.msn.com/investing/10-easy-currency-lessons

    To a greater extent than usual, the movement of currencies is driving the prices of global stocks and bonds and is shaping monetary policies in key emerging markets.

    And, the above link may answer some of your questions.

    Jonathan

    Like

  8. Strong USD

    Could a strong dollar derail Wall Street’s rally?

    http://www.msn.com/en-us/money/investingpro/could-a-strong-dollar-derail-wall-streets-rally/ar-AA6UHAb

    Any thoughts?

    Ali

    Like

  9. The Euro Hedge

    David – On January 22nd, the European Central Bank (ECB) announced a plan to begin a major quantitative easing (QE) program in Europe.

    In an attempt to reach its 2% inflation target and to stop deflation from spreading throughout the continent, the ECB said it would buy sovereign bonds as part of a program to increase its balance sheet by more than €1 trillion Euros over the next two years.

    In 2014, the Euro fell 12% in relation to the U.S. dollar, its worst year against the dollar since 2005. With the ECB committing to asset purchases of at least 60 billion euros per month, the Euro may continue to depreciate against the dollar, which would serve as a headwind for U.S. investors allocating to European stocks.

    For those interested in mitigating the impact of foreign currencies on international equity allocations, it may be time for a currency hedge?

    Maurice
    http://www.amazon.com/Comprehensive-Financial-Planning-Strategies-Advisors/dp/1482240289/ref=sr_1_1?ie=UTF8&qid=1418580820&sr=8-1&keywords=david+marcinko

    Like

  10. Greek Debt Crisis and Chinese Stock Market Crash
    [Black Swan?]

    Two days ago, Greek voters said “No” to the terms of EU bailout in a national referendum. Yesterday, the Shanghai Stock Index fell another 5.9%. Cumulatively, the index has fallen 30+% since reaching its peak in June 12. Which of these two events will likely be the black swan that rocks the US market?

    I don’t think it will be Greece. The Greek economy is a mere 1.7% of the total EU. It’s basically a rounding error. When the first act of this Greek drama was played in 2011, the US market promptly dropped 19%. That was a wealth destruction ten times the size of the entire Greek economy. This just shows the fear of a disaster can be much worse than the disaster itself. Now that we are in the third act of this Greek drama, global markets are more or less immune to it.

    China is an entirely different matter, and it has a potential to become a black swan …

    • The stock market crash there just vaporized $3 trillion worth of investor wealth, all within a month. 99% of those investors are domestic Chinese investors.

    • According to a Goldman Sachs research, Chinese investors are highly leveraged. By some estimate, a 30% loss in market index could translate into a 60% loss to the average investor.

    • The growth engine for the Chinese economy is domestic consumption, not export or investment any more. Domestic consumption has been growing 10% a year in the past few years, you bet it’s going to be affected by the market crash.

    • There are 90 million stock investors in China, larger than the entire communist party membership. They are panicking, fearful, resentful, restless. As they have been conditioned to believe in the party, now they are blaming the party for their losses. The specter of massive single issue social unrest can not be ruled out. China is the second largest economy in the world, and the biggest growth engine, should a massive unrest breakout, the effect will reverberate across the Pacific.

    Now, some mitigating factors …

    • Before the recent 30% tumble, the Chinese market has gone up 150%. Even after this massive tumble, it’s still up about 70% from a year ago. So maybe not all investors lost money.

    • The Chinese stock market, like its internet, is walled in. Foreign investors can only invest in Chinese shares in the Hong Kong market, which is much more mature and stable. This has the effect of containing the economic disaster within China.

    • If you are my client, your exposure to China is about 2%, nearly all of that through the Hong Kong market. You can thank me later for protecting you from a bubble market again ;-).

    In summary, the situation in China bears close watching. The economic impact on us is limited, but fear can not be walled in, fear could spread to other Asian markets and even to our shores. Should that happen, remember what FDR said: “The only thing to fear is fear itself.”

    Michael Zhuang
    [MZ Capital]

    Like

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: